A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors
Clinical trial NCT05355753 · TERMINATED
Trial details
- NCT number
- NCT05355753
- Sponsor
- C4 Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-25
- Primary completion
- 2023-12-19
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.